PER 1.23% 8.0¢ percheron therapeutics limited

next ann:initiation of phase iia trial atl1103, page-20

  1. 14,981 Posts.
    lightbulb Created with Sketch. 51
    ANP looks fine to me and I believe that if they get through trials to a successful product then they will more than likely have a market for it

    I also believe that the market cap will be many, many times it's current one when they eventually do, as a lead up to it

    So I'm buying now, because, whilst peaceAKKI has some valid points, I don't think many stack up for me to caution against buying now because the sp wil be elevated by the time we get through approvals, so any downside in sp risk I see as irrelevant as I will already be largely in substantial profit already

    Anyway just the way I see it, be it right or wrong, but there's too many things pointing to this being a big success coupled with the comments I have just made, to turn me off the stock at these levels now

    Just imo of course
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.